Navigation Tabs
The mutant variant of PNGM-1. H257 was substituted for alanine to study substrate binding. External Resource: Annotation Chains Family Name Domain Identifier Architecture Possible Homology Homology Topology Family Provenance Source (Version) D V-set e7bz3D1 A: alpha bundles X: CNF1/YfiH-like putative cysteine hydrolases H: Bromodomain T: Bromodomain F: V-set ECOD (develop294) C HSP20 e7bz3C1 A: alpha bundles X: CNF1/YfiH-like putative cysteine hydrolases H: Bromodomain T: Bromodomain F: HSP20 ECOD (develop294) B V-set e7bz3B1 A: alpha bundles X: CNF1/YfiH-like putative cysteine hydrolases H: Bromodomain T: Bromodomain F: V-set ECOD (develop294) A V-set e7bz3A1 A: alpha bundles X: CNF1/YfiH-like putative cysteine hydrolases H: Bromodomain T: Bromodomain F: V-set ECOD (develop294)
Chains Accession Short Name Description Provenance Source (Version) ARO:3004571 PNGM-1 PNGM-1 is a subclass B3 metallo-beta-lactamase first identified from a deep-sea sediment meta-genome. PNGM-1 is shown to reduce susceptibility to extended- and broad-spectrum cephalosporins, carbapenems, and penicillins. PNGM-1 is a novel metallo-beta-lactamase which predates the current antibiotic era. CARD (4.0.1)
Chains Accession Gene Family Drug Class Resistance Machanism Provenance Source (Version) ARO:3004570 PNGM beta-lactamase carbapenem, cephalosporin, penicillin beta-lactam antibiotic inactivation CARD (4.0.1)
